Vagge Aldo, Nelson Leonard B
aPediatric Ophthalmology and Ocular Genetics, Wills Eye Hospital, Philadelphia, Pennsylvania, USA bEye Clinic, DiNOGMI, University of Genoa, Genoa, Italy.
Curr Opin Ophthalmol. 2017 Sep;28(5):454-459. doi: 10.1097/ICU.0000000000000409.
The present review article is an update on the current evidence about compliance to the prescribed occlusion treatment for amblyopia. In particular, the authors focus on the predictors and causes of noncompliance and possible interventions to increase it.
Compliance with prescribed occlusion treatment is often challenging. Reported rates of compliance range widely from 49% to 87%. Objective monitoring of occlusion has opened up new research opportunities and allow the design of effective therapeutic regimens. Also, predictors and causes of noncompliance have been investigated and their knowledge may help the clinician to improved compliance with prescribed occlusion treatment for amblyopia.
Although many of the studies assessing the effectiveness of interventions to increase compliance to patching treatment for amblyopia have many limitations, evidences support that use of educational supports, parents, and patient understanding on the importance of patching and written information should be considered to increase compliance with patching.
本综述文章是关于弱视规定遮盖治疗依从性的当前证据的更新。特别是，作者关注不依从的预测因素和原因以及提高依从性的可能干预措施。
遵守规定的遮盖治疗通常具有挑战性。报告的依从率范围广泛，从49%到87%。遮盖的客观监测开辟了新的研究机会，并允许设计有效的治疗方案。此外，已经对不依从的预测因素和原因进行了调查，了解这些因素可能有助于临床医生提高弱视规定遮盖治疗的依从性。
尽管许多评估提高弱视遮盖治疗依从性干预措施有效性的研究有很多局限性，但有证据支持，应考虑使用教育支持、家长和患者对遮盖重要性的理解以及书面信息来提高遮盖的依从性。
